Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 2,542 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: University of California, San Diego; Other
Eligibility: 30 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Diego, California

Conditions: Excessive Daytime Sleepiness
Interventions: ORX142 Tablets, Placebo Tablets; Drug · Other
Lead sponsor: Centessa Pharmaceuticals (UK) Limited; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Lincoln, Nebraska • Eatontown, New Jersey • New York, New York

Conditions: Survivorship, Cognitive Dysfunction, Pain, Depression, Anxiety, Fatigue, Sleep Disturbance
Interventions: Cognitive Dysfunction; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 21 Years and older
Enrollment: 682 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Sleep Apnea Syndromes, Snoring
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 21 Years to 89 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Cardiovascular Diseases
Interventions: Nutrition, Exercise, Stress Management Counseling, usual care; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 45 Years to 75 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Heart Failure, Sleep Disordered Breathing
Interventions: Dapagliflozin, WatchPat; Drug · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Obstructive Sleep Apnea
Interventions: Donepezil, placebo; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Insomnia, Traumatic Brain Injury
Interventions: Computerized Cognitive Behavioral Therapy for Insomnia; Behavioral
Lead sponsor: VA Eastern Colorado Health Care System; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Breast Cancer, Cancer Survivor, Depression, Fatigue, Sexual Dysfunction, Sleep Disorders, Spiritual Concerns
Interventions: study of socioeconomic and demographic variables, fatigue assessment and management, management of therapy complications, psychosocial assessment and care, quality-of-life assessment; Other · Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Sleep Apnea, Obstructive, Craniofacial Abnormalities, Pediatric Disorder
Interventions: Personalized continuous positive airway pressure (CPAP) mask; Device
Lead sponsor: Glenn Green; Other
Eligibility: 1 Year to 18 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Alzheimer's Disease, Insomnia
Interventions: quetiapine; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 55 Years to 90 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Breast Cancer, Fatigue, Sleep Disorders
Interventions: Tamoxifen, triptorelin, Exemestane; Drug
Lead sponsor: ETOP IBCSG Partners Foundation; Network
Eligibility: Up to 120 Years · Female only
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 13
States / cities: Sacramento, California • Fort Collins, Colorado • Norwalk, Connecticut + 7 more

Conditions: Idiopathic Hypersomnia
Interventions: Serdexmethylphenidate, Placebo; Drug · Other
Lead sponsor: Zevra Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 41
States / cities: Birmingham, Alabama • Daphne, Alabama • Guntersville, Alabama + 34 more

Conditions: Obstructive Sleep Apnea
Interventions: CPAP4HealthySleep system; Behavioral
Lead sponsor: Sarah Alismail; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Claremont, California

Conditions: Caregiver Burden, Behavioral and Psychiatric Symptoms of Dementia, Depressive Symptoms, Quality of Life, Psychological Flexibility, Sleep Quality, Positive Aspects of Caregiving
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: Utah State University; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Logan, Utah

Conditions: Sleep Disordered Breathing, Tetraplegia
Interventions: PAP Device Procedure; Procedure
Lead sponsor: Mark S. Nash, Ph.D., FACSM; Other
Eligibility: 18 Years to 65 Years
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obstructive Sleep Apnea (OSA), Snoring, Sleep Quality
Interventions: Exercise; Other
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity Hypoventilation Syndrome
Interventions: BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (venous blood gas and metabolic panel) and data collection from PSG study., BMI greater than or equal to 30kg/m2 scheduled for PSG. Undergo blood draw (arterial blood gas and metabolic panel) and data collection from PSG study.; Other
Lead sponsor: Philips Respironics; Industry
Eligibility: 21 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Hypertension, Obstructive Sleep Apnea
Interventions: Dietary sodium; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 48 Years to 65 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obstructive Sleep Apnea Syndrome
Interventions: Nasal Fluticasone, Placebo; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 5 Years to 12 Years
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Generalized Anxiety Disorder, Sleep Disturbances
Interventions: Not listed
Lead sponsor: Children's National Research Institute; Other
Eligibility: 7 Years to 11 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2009
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Obstructive Sleep Apnea
Interventions: Oral appliance, Oxygen, Oral appliance plus oxygen, No treatment; Device · Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 79 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia Disorder
Interventions: ACT-541468 5 mg, ACT-541468 10 mg, ACT-541468 25 mg, Zolpidem, Placebo 1, Placebo 2; Drug
Lead sponsor: Idorsia Pharmaceuticals Ltd.; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 15
States / cities: Santa Monica, California • Upland, California • Brandon, Florida + 12 more

Conditions: Insomnia Disorder, Mild Traumatic Brain Injury
Interventions: Sleep MAPP Care Pathway; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 2
States / cities: Aurora, Colorado • Tampa, Florida

Search by objective public record fields.

Potential Mechanism of Exercise Impairment in OSA

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms

Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors

Novel Strategies for Reducing Heart Disease Risk Disparities

SGLT2-Inhibitors for Sleep Apnea in Heart Failure

The Impact of Arousal Threshold in Obstructive Sleep Apnea

University of Colorado - Restoring Efficient Sleep After TBI

Quality of Life in African-American or Caucasian Female Breast Cancer Survivors

3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea

Quetiapine for the Treatment of Insomnia in Alzheimer's Disease

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Study of SDX in Patients With Idiopathic Hypersomnia (IH)

Promoting the Use of CPAP Therapy Among OSA Patients

Acceptance Commitment Therapy for Caregivers of People with Memory Loss

Sleep Disordered Breathing

The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy

Obesity Hypoventilation Syndrome Prevalence Study

Nocturnal Hypertension and Non-Dipping Blood Pressure

Steroids for Pediatric Apnea Research in Kids

Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD)

Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea

Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

Sleep MAPP in the Polytrauma/TBI System of Care